IP Library Granted Patent US 8,939,947
Granted Patent B2
US 8,939,947 · App. 13/776,517 · Granted Jan 27, 2015

Systems and methods for radiographically identifying an access port

Inventors: Ketan K. Maniar (Mahwah, NJ); Sean M. Worthen (West Jordan, UT); Kelly B. Powers (North Salt Lake, UT)
Assignee: C. R. Bard, Inc.
A61M39/0208A61M39/0247A61B6/12A61M2039/0211A61M2039/0238A61M2205/32A61M2205/582A61M2205/6054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,939,947
App. No.
13/776,517
Granted
Jan 27, 2015
Kind
B2
Abstract

An access port for subcutaneous implantation is disclosed. Such an access port may comprise a body for capturing a septum for repeatedly inserting a needle therethrough into a cavity defined within the body. Further, the access port may include at least one feature structured and configured for identification of the access port subsequent to subcutaneous implantation. Methods of identifying a subcutaneously implanted access port are also disclosed. For example, a subcutaneously implanted access port may be provided and at least one feature of the subcutaneously implanted access port may be perceived. Further, the subcutaneously implanted access port may be identified in response to perceiving the at least one feature. In one embodiment, an identification feature is included on an insert that is incorporated into the access port so as to be visible after implantation via x-ray imaging technology.

Claims (19)

1. A power-injectable access port for providing subcutaneous access to a patient, comprising:

a port body defining a fluid cavity, the port body formed from a base material; and

a radiopaque insert separate from the port body, the radiopaque insert formed from a material comprising a mixture of the base material and a radiopaque material, the radiopaque insert including an identification feature that is observable via x-ray imaging technology subsequent to subcutaneous implantation of the access port, the identification feature identifying the access port as a power-injectable port.

2. The power-injectable access port according to claim 1 , wherein the radiopaque insert is visible from a surface of the port prior to subcutaneous implantation.

3. The power-injectable access port according to claim 1 , wherein the radiopaque insert is positioned substantially flush with a bottom surface of the access port.

4. The power-injectable access port according to claim 1 , wherein the base material is a polycarbonate and the radiopaque material includes tungsten.

5. The power-injectable access port according to claim 1 , wherein the base material is a polysulfone and the radiopaque material includes bismuth trioxide.

6. The power-injectable access port according to claim 1 , wherein the base material includes acetyl resin and the radiopaque material includes a metal oxide.

7. The power-injectable access port according to claim 6 , wherein the metal oxide includes bismuth trioxide.

8. The power-injectable access port according to claim 1 , wherein the port body includes a base portion and a cap portion joined to the base portion over a septum that is captured therebetween.

9. The power-injectable access port according to claim 8 , wherein the radiopaque insert is encapsulated in the base portion.

10. The power-injectable access port according to claim 1 , wherein the radiopaque insert has an annular shape with three vertices configured to surround an outer perimeter of the access port.

11. The power-injectable access port according to claim 10 , wherein the identification feature includes a “C” letter-shaped hole and a “T” letter-shaped hole at each of the three vertices.

12. The power-injectable access port according to claim 1 , wherein the identification feature includes alphanumeric indicia.

13. The power-injectable access port according to claim 12 , wherein the alphanumeric indicia includes the letters “C” and “T”.

14. The power-injectable access port according to claim 1 , wherein the port body defines a first fluid cavity and a second fluid cavity, and wherein a radiopaque insert outer perimeter is defined by a first triangle connected to a second triangle.

15. The power-injectable access port according to claim 14 , wherein the first triangle is positioned coincident with an axis passing through the first fluid cavity and the second triangle is positioned coincident with an axis passing through the second fluid cavity.

16. The power-injectable access port according to claim 15 , wherein the radiopaque insert includes the letters “C” and “T”.

17. The power-injectable access port according to claim 16 , wherein the “C” is defined by a cutout in the first triangle, and the “T” is defined by a cutout in the second triangle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: C. R. BARD, INC.
To: BARD PERIPHERAL VASCULAR, INC.
Reel/Frame 043129/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2017
From: MANIAR, KETAN K.; WORTHEN, SEAN M.; POWERS, KELLY B.
To: C. R. BARD, INC.
Reel/Frame 043094/0771 →
Continuity (8)
Division 13250909 · Sep 30, 2011
Division 12796133 · Jun 8, 2010
Continuation In Part 12610084 · Oct 30, 2009
Continuation In Part 12420028 · Apr 7, 2009
Continuation In Part 11368954 · Mar 6, 2006
Provisional Application 61110507 · Oct 31, 2008
Provisional Application 60658518 · Mar 4, 2005
Related Publication 20130172733A1 · Jul 4, 2013